Modification of human BMSC with nanoparticles of polymeric biomaterials and plasmid DNA for BMP-2 secretion

Journal of Surgical Research

Volumn 183, Issue 1, 2013, Pages 8-17

  Wang, Yufu ^a,b   Mostafa, Nesrine Z ^a   Hsu, Charlie Y M ^a   Rose, Laura ^a   Kucharki, Cezary ^a   Yan, Jinglong ^b   Jiang, Hongxing ^a   Uludaǧ, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

BMP 2; Human bone marrow stromal cells; ; Linoleic acid substituted polyethylenimine; Osteogenic activity; Polymeric biomaterials; Transfection

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BONE MORPHOGENETIC PROTEIN 2; NANOCARRIER; PLASMID DNA; PLASMID VECTOR; POLYETHYLENEIMINE; POLYETHYLENEIMINE 2; POLYETHYLENEIMINE 25; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; CELL ASSAY; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEASIBILITY STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO GENE TRANSFER; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION;

ADOLESCENT; ADULT; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; MIDDLE AGED; NANOPARTICLES; OSTEOGENESIS; PLASMIDS; POLYETHYLENEIMINE; STEM CELL TRANSPLANTATION; TRANSGENES; YOUNG ADULT;

EID: 84879072133     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.11.061     Document Type: Article

References (40)

1. W.K. Aicher, H.J. Buhring, and M. Hart Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells-potential and pitfalls Adv Drug Deliv Rev 63 2011 342
2. E. Jones, and X. Yang Mesenchymal stem cells and bone regeneration: current status Injury 42 2011 562
3. A.I. Caplan Why are MSCs therapeutic? New data: new insight J Pathol 217 2009 318
4. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499
5. J.C. Reichert, A. Cipitria, and D.R. Epari A tissue engineering solution for segmental defect regeneration in load-bearing long bones Sci Transl Med 4 2012 141
6. S. Srouji, D. Ben-David, and O. Fromigue Lentiviral-mediated integrin alpha5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial long-bone defects Hum Gene Ther 23 2012 167
7. B.T. Feeley, A.H. Conduah, and O. Sugiyama In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models J Orthop Res 24 2006 1709
8. C. Xiao, H. Zhou, and S. Ge Repair of orbital wall defects using biocoral scaffolds combined with bone marrow stem cells enhanced by human bone morphogenetic protein-2 in a canine model Int J Mol Med 26 2010 517
9. A.J. Ditto, P.N. Shah, and Y.H. Yun Non-viral gene delivery using nanoparticles Expert Opin Drug Deliv 6 2009 1149
10. T. Niidome, and L. Huang Gene therapy progress and prospects: nonviral vectors Gene Ther 9 2002 1647
11. V. Labhasetwar Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery Curr Opin Biotechnol 16 2005 674
12. U. Lungwitz, M. Breunig, and T. Blunk Polyethylenimine-based non-viral gene delivery systems Eur J Pharm Biopharm 60 2005 247
13. J.K. Raty, H.P. Lesch, and T. Wirth Improving safety of gene therapy Curr Drug Saf 3 2008 46
14. B.F. Benabdallah, E. Allard, and S. Yao Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-solution protein delivery platform Cytotherapy 12 2010 394
15. L. Meinel, S. Hofmann, and O. Betz Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2 Biomaterials 27 2006 4993
16. N.K.F. Chen, S.Y. Tan, and G. Udolph Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy Gene Ther 17 2010 592
17. C. Madeira, S.C. Ribeiro, and I.S. Pinheiro Gene delivery to human bone marrow mesenchymal stem cells by microporation J Biotechnol 151 2011 130
18. C. Madeira, R.D. Mendes, and S.C. Ribeiro Nonviral gene delivery to mesenchyme stem cells using cationic liposomes for gene and cell therapy J Biomed Biotechnol 2010 2010 735349
19. N.Y. Kim, Y.B. Choi, and C.I. Kang An hydrophobically modified arginine peptide vector system effectively delivers DNA into human mesenchymal stem cells and maintains transgene expression with differentiation J Gene Med 12 2010 779
20. K.C. Bahadur, B. Landry, and H.M. Aliabadi Lipid substitution on low molecular weight (0.6-2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression Acta Biomater 7 2011 2209
21. A. Neamnark, O. Suwantong, and R.K. Bahadur Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression Mol Pharm 6 2009 1798
22. C.Y. Hsu, M. Hendzel, and H. Uludag Improved transfection efficiency of an aliphatic lipid substituted 2 kDa polyethylenimine is attributed to enhanced nuclear association and uptake in rat bone marrow stromal cell J Gene Med 13 2010 46
23. L.C. Rose, C. Kucharski, and H. Uludag Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model Biomaterials 33 2012 3363
24. H. Jiang, C. Secretan, and T. Gao The development of osteoblasts from stem cells to supplement fusion of the spine during surgery for AIS Stud Health Technol Inform 123 2006 467
25. O. Frank, M. Heim, and M. Jakob Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro J Cell Biochem 85 2002 737
26. S. Li, and L. Huang Nonviral gene therapy: promises and challenges Gene Ther 7 2000 31
27. H. Lv, S. Zhang, and B. Wang Toxicity of cationic lipids and cationic polymers in gene delivery J Control Release 114 2006 100
28. G. Schmidmaier, R. Capanna, and B. Wildemann Bone morphogenetic proteins in critical-size bone defects: what are the options? Injury 40 suppl 3 2009 S39
29. A.W. Baltzer, and J.R. Lieberman Regional gene therapy to enhance bone repair Gene Ther 11 2004 344
30. J. Park, J. Ries, and K. Gelse Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: A comparison of adenoviral vectors and liposomes Gene Ther 10 2003 1089
31. D. Gazit, G. Turgeman, and P. Kelley Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy J Gene Med 1 1999 121
32. G. Rawadi, B. Vayssiere, and F. Dunn BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop J Bone Miner Res 18 2003 1842
33. H.M. Ryoo, M.H. Lee, and Y.J. Kim Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells Gene 366 2006 51
34. K.R. Dai, X.L. Xu, and T.T. Tang Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone Calcif Tissue Int 77 2005 55
35. T.G. Park, J.H. Jeong, and S.W. Kim Current status of polymeric gene delivery systems Adv Drug Deliv Rev 58 2006 467
36. M.W. Ronsyn, J. Daans, and G. Spaepen Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord BMC Biotechnol 7 2007 90
37. T. Luo, W. Zhang, and B. Shi Enhanced regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery Clin Oral Implants Res 23 2012 467
38. J.C. Wallmichrath, G.B. STrak, and U. Kneser Epidermal growth factor (EGF) transfection of human bone marrow stromal cells in bone tissue engineering J Cell Mol Med 13 2009 2593
39. D.L. Thompson, K.D. Lum, and S.C. Nygaard The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice: new insights into osteoblast and adipocyte differentiation J Bone Miner Res 13 1998 195
40. N.Z. Mostafa, R. Fitzsimmons, and P.W. Major Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2 Connect Tissue Res 53 2012 117